Founder Directory

NewLimit

Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare

Last round: Series B Founders Fund, $130M Series B in 2025

ROME Therapeutics

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals

Last round: Series B Andreessen Horowitz, $50M Series B in 2021, $70M valuation

Hoxton Farms

Grow real animal fat without the animals for delicious, cruelty-free, sustainable ingredient Biotech Sustainability

Last round: Series A Founders Fund, $22M Series A in 2022

Kernel

Kernel is a neuroscience company that specializes in developing brain-recording technologies. Biotech Life Science

Last round: Series C Khosla Ventures, $153M Series C in 2020

Synchron

Restore lives by deciphering the neural code of the brain Biotech Healthcare Hardware

Last round: Series C Khosla Ventures, $75M Series C in 2022

Clear Labs

Clear Labs is a provider of a fully-automated sequencing platform for turnkey diagnostics. Biotech Healthcare Robotics Hardware

Last round: Series C Khosla Ventures, $58M Series C in 2020

BioAge Labs

BIOAGE targets aging to develop drugs that treat severe diseases Biotech

Last round: Series D Andreessen Horowitz, $170M Series D in 2024

Karius

Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare

Last round: Series B Khosla Ventures, $165M Series B in 2020

CAMP4 Therapeutics

BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech

Last round: Series B Andreessen Horowitz, $100M Series B in 2022

Pendulum Therapeutics

Pendulum Therapeutics improves health through products targeting the microbiome. Biotech Healthcare

Last round: Series C Sequoia, Khosla Ventures, $54M Series C in 2021

Mirvie

Creates precise, actionable, and non-invasive tests for maternal-fetal health Biotech Healthcare

Last round: Series B Khosla Ventures, $45M Series B in 2022, $155M valuation

Loyal

We're developing medicines that help dogs live healthier, longer. Biotech Pets Healthcare

Last round: Series A Khosla Ventures, $27M Series A in 2021

Teckro

Teckro is a life science technology company that is rethinking every element of clinical research. Biotech Healthcare Clinical Research

Last round: Series C Founders Fund, $25M Series C in 2021

Zeit Medical

Building devices and software to provide brain health monitoring for neurology injury patients Biotech Healthcare Medical Device

Last round: Seed Y Combinator, $2M Seed in 2021

Elemental Machines

Smart lab platform delivers powerful, data-driven insights that improve R&D, laboratory operations, and manufacturing outcomes. Biotech SaaS

Last round: Series A Founders Fund, $2M Series A in 2020

Hound Labs

Hound Labs develops ultra-sensitive technology for non-invasive breath measurement. Biotech Cannabis Testing

Last round: Series D Benchmark, $20M Series D in 2021

Cofactor Genomics

Experimental Design, Next-generation sequencing, Advanced Analysis and Visualization Biotech Healthcare Clinical Trials Diagnostics

Last round: Series A Y Combinator, $7M Series A in 2021

Indee Labs

Indee Labs is unlocking gene-modified cell therapy for the masses with scalable hardware for gene delivery. Biotech Hardware

Last round: Growth Founders Fund, Y Combinator, Raised $3M in 2021